Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

32.87 -0.77 (-2.29%)
Official Closing Price Updated: 4:15 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Moderna (MRNA) Stock Is Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its list of top short ideas for the second half of 2025. 
Via StockStory
Topics ETFs Stocks World Trade
Delta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio?
Top performers last week: Venture Global up 18.96% on LNG deal, SoFi up 14.29% on analyst coverage, Delta up 11.91% on earnings, Unity up 9.17% on price forecast, Moderna up 10.66% on FDA approval, PTC... 
Via Benzinga
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
What's Driving the Market Sentiment Around Moderna?
Via Benzinga
2 Stocks Under $50 on Our Watchlist and 1 to Ignore
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 vaccine patent dispute. 
Via Benzinga
Topics Intellectual Property
Should Politicians Be Allowed to Trade Stocks? The Big Debate
A growing chorus of lawmakers, ethics watchdogs, and concerned citizens are reigniting a high-stakes debate: Should U.S. politicians be allowed to buy and sell stocks while in office? Amidst rising... 
Via MarketMinute
Topics Artificial Intelligence Electric Vehicles
Why Moderna (MRNA) Stock Is Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug Administration (FDA) granted full approval for its Spikevax COVID-19 vaccine to be... 
Via StockStory
Topics Artificial Intelligence
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older
The vaccine was previously available for pediatric populations under Emergency Use Authorization only. 
Via Stocktwits
Market Monitor News July 09 BMO (Moderna & Merit Medical System UP - Solar & Bank Stocks DOWN)
Wall Street Holds Its Breath: Tariff Tantrums, Solar Slaps, and a Surge from Moderna 
Via Chartmill
Top S&P500 movers in Tuesday's session
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks
Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant individuals. 
Via Benzinga
Discover which S&P500 stocks are making waves on Tuesday.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates. 
Via Stocktwits
2 Beaten-Down Stocks to Buy and Hold
Via The Motley Fool
Topics Death
Where Will Moderna Be in 10 Years?
Via The Motley Fool
Why Moderna Stock Was So Healthy This Week
Via The Motley Fool
RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid concerns about rare side effects. 
Via Benzinga
CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panel
The agency expanded its RSV and meningococcal vaccine guidance to cover younger age groups and new formulations. 
Via Stocktwits
Topics Government
Which S&P500 stocks are moving on Wednesday?
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
RFK Jr. Just Did The Unexpected. He Helped Moderna.
The new Health Secretary reportedly recommended Moderna's RSV vaccine for a broader group of adults. 
Via Investor's Business Daily
Explore the top gainers and losers within the S&P500 index in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
Tuesday's session: top gainers and losers in the S&P500 index
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday. 
Via Chartmill
Got $200? 2 Biotech Stocks to Buy and Hold Forever
Via The Motley Fool
Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?
Shares have long struggled, but things could be looking up for Moderna stock in the face of new flu shot results. 
Via Investor's Business Daily
Moderna's mRNA Flu Vaccine Outperforms Standard Shots
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase 3 study. 
Via Benzinga
What's going on in today's pre-market session: S&P500 movers
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial
The data is key to receiving approvals for both the individual vaccine candidate and the company’s seasonal flu-COVID combination vaccine candidate. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.